Immediate Impact

3 from Science/Nature 62 standout
Sub-graph 1 of 23

Citing Papers

Natural killer cell therapies
2024 StandoutNature
Allogeneic BCMA-targeting CAR T cells in relapsed/refractory multiple myeloma: phase 1 UNIVERSAL trial interim results
2023 Standout
6 intermediate papers

Works of Philipp Schütt being referenced

Soluble MICA as an independent prognostic factor for the overall survival and progression-free survival of multiple myeloma patients
2007
Immune parameters in multiple myeloma patients: influence of treatment and correlation with opportunistic infections
2006

Author Peers

Author Last Decade Papers Cites
Philipp Schütt 115 233 176 194 23 583
Phillip Periman 169 282 132 253 26 677
DG Poplack 84 262 138 210 22 706
AR Zander 68 229 274 176 21 631
Eugene M. Berkman 74 213 351 216 20 734
K. Quabeck 98 119 343 175 34 679
James Fetten 203 256 104 99 28 652
Joseph Allen Stein 74 125 86 179 32 598
Nora Ku 123 167 248 201 24 578
Leslie Garrison 140 106 147 210 23 687
Roula Farah 81 87 217 226 39 666

All Works

Loading papers...

Rankless by CCL
2026